Category: Top Story
-
Pfizer shares slip despite encouraging trial results for eczema treatment
Pfizer Inc (NYSE:PFE) shares declined 1.15% to $26.74 in premarket trading Monday, even after the pharmaceutical company reported positive mid-stage clinical trial results for its experimental antibody therapy targeting atopic dermatitis. The drugmaker said the antibody, tilrekimig, showed meaningful improvement in symptoms of the chronic inflammatory skin condition during the study. According to Pfizer, a…
-
Hims surges 44% after report Novo Nordisk may offer weight-loss drugs on its platform
Novo Nordisk (NYSE:NVO) is planning to distribute its weight-loss medications through the telehealth platform operated by Hims & Hers Health (NYSE:HIMS), signaling an unexpected thaw in relations between the companies after a recent legal clash, Bloomberg reported over the weekend. Shares of Hims — which have fallen roughly 51% so far this year — jumped…
-
Yardeni warns meltdown risk rising as Polymarket recession odds climb to 37%
Expectations of a U.S. recession have risen notably since the escalation of conflict in the Middle East, as investors grow more concerned about the economic consequences of higher energy prices and geopolitical instability. U.S. stock futures were lower in early Monday trading, with S&P 500 futures declining 1.4%. Data from prediction platform Polymarket shows the…
-
Live Nation nears settlement in U.S. antitrust case without selling Ticketmaster, report says
Live Nation Entertainment (NYSE:LYV) is reportedly approaching a settlement with U.S. regulators in a federal antitrust lawsuit that could allow the company to keep its Ticketmaster division, according to a Bloomberg News report on Monday citing people familiar with the matter. The U.S. Department of Justice and more than two dozen states filed the lawsuit…
-
Uranium ensures energy sovereignty: How investors can profit with Stallion Uranium, NexGen Energy, and Constellation Energy – which stock is the favourite?
In times of war, uranium rises from a cyclical commodity to a strategic asset. Even in Germany, people are aware of the dilemma that the energy policy of recent years has maneuvered them into: either they are dependent on imports, or they have to think more openly about technology, for example, nuclear power. The Canadian…
-
Billion-Dollar Opportunity from the NDAA: NEO Battery Materials benefits from the US shift away from Chinese supply chains
In the world of battery startups, the path from promising laboratory formula to a delivered product is fraught with pitfalls. Technology promises fizzle out, production ramp-ups stall, and customers walk away. It is a business where confidence can quickly evaporate. This makes the development of a Canadian company based in Toronto over the past few…
-
Extended Crude Oil Surge, Jobs Data Trigger Sell-Off On Wall Street
Stocks moved sharply lower during trading on Friday, adding to the losses posted in the previous session. With the steep losses on the day, the Dow and the Nasdaq dropped to their lowest closing levels in over three months and the S&P 500 hit a two-month closing low. The major averages all finished the day…
-
NorthStrive urges enVVeno to pause clinical spending, calls for shareholder vote on strategic options
An activist investor holding a stake in enVVeno Medical Corporation has called on the company’s board to halt clinical spending and allow shareholders to vote on potential strategic alternatives, including liquidation or a merger. NorthStrive Companies Inc. said its subsidiary NorthStrive Fund II LP, which owns about 5.05% of enVVeno’s outstanding shares, sent an open…
-
Escalating Middle East conflict, soaring oil prices and weak payrolls data pressure U.S. market outlook: Dow Jones, S&P 500 and Nasdaq Futures
Dow Jones, S&P 500 and Nasdaq index futures are currently pointing to a sharply lower open on Friday, with stocks likely to see further downside following the weakness seen in the previous session. The futures saw further downside following the release of a closely watched Labor Department report showing U.S. unemployment unexpectedly decreased in the…
-
U.S. jobs report shows payroll decline of 92,000 in February as unemployment rate rises to 4.4%
Employment in the U.S. unexpectedly decreased in the month of February, according to a closely watched report released by the Labor Department on Friday. The report said non-farm payroll employment slumped by 92,000 jobs in February after jumping by a downwardly revised 126,000 jobs in January. Economists had expected employment to increase by 60,000 jobs…